Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection

Accurate rapid diagnostic tests for SARS-CoV-2 infection could contribute to clinical and public health strategies to manage the COVID-19 pandemic. Point-of-care antigen and molecular tests to detect current infection could increase access to testing and early confirmation of cases, and expediate clinical and public health management decisions that may reduce transmission.

Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection | Litlas